|
1
|
Denton EJ, Hart D, Wainer Z, Wright G,
Russell PA and Conron M: Changing trends in diagnosis, staging,
treatment and survival in lung cancer: Comparison of three
consecutive cohorts in an Australian lung cancer centre. Intern Med
J. 46:946–954. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Osińska I and Domagała-Kulawik J:
Bronchoalveolar lavage in lung cancer-diagnostic value and
assessment of the anti-cancer immune response. Postepy Hig Med
Dosw. 67:1119–1127. 2013.(In Polish). View Article : Google Scholar
|
|
3
|
Giangreco A, Groot KR and Janes SM: Lung
cancer and lung stem cells: Strange bedfellows? Am J Respir Crit
Care Med. 175:547–553. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Grivaux M, Debieuvre D, Herman D,
Lemonnier C, Marcos JM, Crequit J, Vuillermoz-Blas S, Barre P,
Saillour M and Martin F: Early mortality in lung cancer: French
prospective multicentre observational study. BMC Pulm Med.
16:452016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Whiteside TL: Stimulatory role of exosomes
in the context of therapeutic anti-cancer vaccines. Biotarget.
1:52017. View Article : Google Scholar
|
|
6
|
Al-Mulla F, Bitar MS, Al-Maghrebi M,
Behbehani AI, Al-Ali W, Rath O, Doyle B, Tan KY, Pitt A and Kolch
W: Raf kinase inhibitor protein RKIP enhances signaling by glycogen
synthase kinase-3β. Cancer Res. 71:1334–1343. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Noma D, Inamura K, Matsuura Y, Ninomiya H,
Ichinose J, Nakao M, Mun M, Ishikawa Y and Okumura S:
ALK-rearranged lung adenocarcinoma showing intra-bronchial
protrusion: A case of actually peripheral origin with a rare
spreading pattern. Biotarget. 1:152017. View Article : Google Scholar
|
|
8
|
He P, Liang J, Shao T, Guo Y, Hou Y and Li
Y: HDAC5 promotes colorectal cancer cell proliferation by
up-regulating DLL4 expression. Int J Clin Exp Med. 8:6510–6516.
2015.PubMed/NCBI
|
|
9
|
Chen J, Xia J, Yu YL, Wang SQ, Wei YB,
Chen FY, Huang GY and Shi JS: HDAC5 promotes osteosarcoma
progression by upregulation of Twist 1 expression. Tumour Biol.
35:1383–1387. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fang Q, Xu T, Wu C, Zhou S and Sun H:
Biotargets in neural regeneration. Biotarget. 1:62017. View Article : Google Scholar
|
|
11
|
Xiao H, Jiao J, Wang L, O'Brien S, Newick
K, Wang LC, Falkensammer E, Liu Y, Han R, Kapoor V, et al: HDAC5
controls the functions of Foxp3+ T-regulatory and
CD8+ T cells. Int J Cancer. 138:2477–2486. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guise AJ and Cristea IM: Approaches for
studying the subcellular localization, interactions, and regulation
of histone deacetylase 5 (HDAC5). Methods Mol Biol. 1436:47–84.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Greco TM, Yu F, Guise AJ and Cristea IM:
Nuclear import of histone deacetylase 5 by requisite nuclear
localization signal phosphorylation. Mol Cell Proteomics. 10(M110):
0043172011.PubMed/NCBI
|
|
14
|
Lin M, Zhu Q, Wang J, Yang W, Fan H, Yi J
and Jiang M: Molecules involved in acrosomal exocytosis and
cortical granule exocytosis. Biotarget. 1:112017. View Article : Google Scholar
|
|
15
|
Li A, Liu Z, Li M, Zhou S, Xu Y, Xiao Y
and Yang W: HDAC5, a potential therapeutic target and prognostic
biomarker, promotes proliferation, invasion and migration in human
breast cancer. Oncotarget. 7:37966–37978. 2016.PubMed/NCBI
|
|
16
|
Feng GW, Dong LD, Shang WJ, Pang XL, Li
JF, Liu L and Wang Y: HDAC5 promotes cell proliferation in human
hepatocellular carcinoma by up-regulating Six1 expression. Eur Rev
Med Pharmacol Sci. 18:811–816. 2014.PubMed/NCBI
|
|
17
|
Liu J, Gu J, Feng Z, Yang Y, Zhu N, Lu W
and Qi F: Both HDAC5 and HDAC6 are required for the proliferation
and metastasis of melanoma cells. J Transl Med. 14:72016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Milde T, Oehme I, Korshunov A,
Kopp-Schneider A, Remke M, Northcott P, Deubzer HE, Lodrini M,
Taylor MD, von Deimling A, et al: HDAC5 and HDAC9 in
medulloblastoma: Novel markers for risk stratification and role in
tumor cell growth. Clin Cancer Res. 16:3240–3252. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT,
Xia YJ, Ye ZY and Tao HQ: MicroRNA-101 is down-regulated in gastric
cancer and involved in cell migration and invasion. Eur J Cancer.
46:2295–2303. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Q, Zheng JM, Chen JK, Yan XL, Chen HM,
Nong WX and Huang HQ: Histone deacetylase 5 promotes the
proliferation of glioma cells by upregulation of Notch 1. Mol Med
Rep. 10:2045–2050. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Medenica M, Medenica M, Bojović O,
Soldatović I and Durutović I: Changing trends in incidence of lung
cancer by histological type in Montenegro. Srp Arh Celok Lek.
142:23–28. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hsieh TH, Hsu CY, Tsai CF, Long CY, Wu CH,
Wu DC, Lee JN, Chang WC and Tsai EM: HDAC inhibitors target HDAC5,
upregulate microRNA-125a-5p, and induce apoptosis in breast cancer
cells. Mol Ther. 23:656–666. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang M, Pan Y, Dorfman RG, Czen Z, Liu F,
Zhou Q, Huang S, Zhang J, Yang D and Liu J: AR-42 induces apoptosis
in human hepatocellular carcinoma cells via HDAC5 inhibition.
Oncotarget. 7:22285–22294. 2016.PubMed/NCBI
|
|
24
|
Fan J, Lou B, Chen W, Zhang J, Lin S, Lv
FF and Chen Y: Down-regulation of HDAC5 inhibits growth of human
hepatocellular carcinoma by induction of apoptosis and cell cycle
arrest. Tumour Biol. 35:11523–11532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fabian J, Opitz D, Althoff K, Lodrini M,
Hero B, Volland R, Beckers A, de Preter K, Decock A, Patil N, et
al: MYCN and HDAC5 transcriptionally repress CD9 to trigger
invasion and metastasis in neuroblastoma. Oncotarget.
7:66344–66359. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou L, Yu L, Ding G, Chen W, Zheng S and
Cao L: Overexpressions of DLL4 and CD105 are associated with poor
prognosis of patients with pancreatic ductal adenocarcinoma. Pathol
Oncol Res. 21:1141–1147. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang QB, Ma X, Li HZ, Ai Q, Liu SW, Zhang
Y, Gao Y, Fan Y, Ni D, Wang BJ and Zhang X: Endothelial Delta-like
4 (DLL4) promotes renal cell carcinoma hematogenous metastasis.
Oncotarget. 5:3066–3075. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zeng J, Shi R, Cai CX, Liu XR, Song YB,
Wei M and Ma WL: Increased expression of Six1 correlates with
progression and prognosis of prostate cancer. Cancer Cell Int.
15:632015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Z, Tian T, Lv F, Chang Y, Wang X, Zhang
L, Li X, Li L, Ma W, Wu J and Zhang M: Six1 promotes proliferation
of pancreatic cancer cells via upregulation of cyclin D1
expression. PLoS One. 8:e592032013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Z, Tian T, Hu X, Zhang X, Li L, Nan F,
Chang Y, Wang X, Sun Z, Lv F, et al: Targeting Six1 by
lentivirus-mediated RNA interference inhibits colorectal cancer
cell growth and invasion. Int J Clin Exp Pathol. 7:631–639.
2014.PubMed/NCBI
|
|
31
|
Fender AW, Nutter JM, Fitzgerald TL,
Bertrand FE and Sigounas G: Notch-1 promotes stemness and
epithelial to mesenchymal transition in colorectal cancer. J Cell
Biochem. 116:2517–2527. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li L, Zhao F, Lu J, Li T, Yang H, Wu C and
Liu Y: Notch-1 signaling promotes the malignant features of human
breast cancer through NF-κB activation. PLoS One. 9:e959122014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li JL, Sainson RC, Oon CE, Turley H, Leek
R, Sheldon H, Bridges E, Shi W, Snell C, Bowden ET, et al:
DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy
in vivo. Cancer Res. 71:6073–6083. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Q, Yuan Y, Cui J, Xiao T and Jiang
D: Paeoniflorin inhibits proliferation and invasion of breast
cancer cells through suppressing Notch-1 signaling pathway. Biomed
Pharmacother. 78:197–203. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wushou A, Hou J, Zhao YJ and Shao ZM:
Twist-1 up-regulation in carcinoma correlates to poor survival. Int
J Mol Sci. 15:21621–21630. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang N, Guo D, Zhao YY, Dong CY, Liu XY,
Yang BX, Wang SW, Wang L, Liu QG, Ren Q, et al: TWIST-1 promotes
cell growth, drug resistance and progenitor clonogenic capacities
in myeloid leukemia and is a novel poor prognostic factor in acute
myeloid leukemia. Oncotarget. 6:20977–20992. 2015.PubMed/NCBI
|
|
37
|
Zhong L, Sun S, Shi J, Cao F, Han X and
Chen Z: MicroRNA-125a-5p plays a role as a tumor suppressor in lung
carcinoma cells by directly targeting STAT3. Tumour Biol.
39:10104283176975792017.doi: 10.1177/1010428317697579. View Article : Google Scholar : PubMed/NCBI
|
